Celsion Corporation [NASDAQ: CLSN] gained 12.42% on the last trading session, reaching $1.72 price per share at the time. The company report on January 28, 2021 that Celsion Corporation Files Provisional U.S. Patent Application for a Broad Range of Next Generation DNA Vaccines.
The PLACCINE Platform Technology is Conceived to Enable Rapid Development of Vaccines That Can Address a Broad Range of Infectious Agents, including SARS-Associated Coronavirus (SARS-CoV).
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
Patent Filing Claims a Novel Composition of Multiple Antigens and Use of a Synthetic Nano Delivery Technology Platform for Preventing and Clearing Infectious Agents.
Celsion Corporation represents 73.23 million in outstanding shares, while the company has a total market value of $95.00 million with the latest information. CLSN stock price has been found in the range of $1.55 to $1.77.
If compared to the average trading volume of 8.31M shares, CLSN reached a trading volume of 17176694 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Celsion Corporation [CLSN]:
Oppenheimer have made an estimate for Celsion Corporation shares, keeping their opinion on the stock as Perform, with their previous recommendation back on July 16, 2020. The new note on the price target was released on July 14, 2020, representing the official price target for Celsion Corporation stock. Previously, the target price had yet another raise to $7, while Maxim Group analysts kept a Buy rating on CLSN stock.
The Average True Range (ATR) for Celsion Corporation is set at 0.21, with the Price to Sales ratio for CLSN stock in the period of the last 12 months amounting to 189.99. The Price to Book ratio for the last quarter was 3.13.
Trading performance analysis for CLSN stock
Celsion Corporation [CLSN] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 25.55. With this latest performance, CLSN shares gained by 117.31% in over the last four-week period, additionally plugging by 45.76% over the last 6 months – not to mention a rise of 22.86% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CLSN stock in for the last two-week period is set at 66.33, with the RSI for the last a single of trading hit 67.67, and the three-weeks RSI is set at 65.52 for Celsion Corporation [CLSN]. The present Moving Average for the last 50 days of trading for this stock 0.9256, while it was recorded at 1.5120 for the last single week of trading, and 1.3735 for the last 200 days.
Celsion Corporation [CLSN]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Celsion Corporation [CLSN] shares currently have an operating margin of -4113.09. Celsion Corporation’s Net Margin is presently recorded at -3370.31.
Return on Total Capital for CLSN is now -73.22, given the latest momentum, and Return on Invested Capital for the company is -62.48. Return on Equity for this stock declined to -95.15, with Return on Assets sitting at -39.59. When it comes to the capital structure of this company, Celsion Corporation [CLSN] has a Total Debt to Total Equity ratio set at 77.86. Additionally, CLSN Total Debt to Total Capital is recorded at 43.77, with Total Debt to Total Assets ending up at 29.61. Long-Term Debt to Equity for the company is recorded at 62.55, with the Long-Term Debt to Total Capital now at 35.17.
Reflecting on the efficiency of the workforce at the company, Celsion Corporation [CLSN] managed to generate an average of -$581,087 per employee. Receivables Turnover for the company is 11.15 with a Total Asset Turnover recorded at a value of 0.01.Celsion Corporation’s liquidity data is similarly interesting compelling, with a Quick Ratio of 3.70 and a Current Ratio set at 3.70.
Celsion Corporation [CLSN]: An earnings per share (EPS) analysis
With the latest financial reports released by the company, Celsion Corporation posted -0.1/share EPS, while the average EPS was predicted by analysts to be reported at -0.2/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 50.00%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CLSN.
An analysis of insider ownership at Celsion Corporation [CLSN]
There are presently around $9 million, or 11.00% of CLSN stock, in the hands of institutional investors. The top three institutional holders of CLSN stocks are: VANGUARD GROUP INC with ownership of 1,269,770, which is approximately -5.604% of the company’s market cap and around 1.25% of the total institutional ownership; BLACKROCK INC., holding 709,245 shares of the stock with an approximate value of $1.22 million in CLSN stocks shares; and MORGAN STANLEY, currently with $1.16 million in CLSN stock with ownership of nearly 161355.263% of the company’s market capitalization.
Positions in Celsion Corporation stocks held by institutional investors increased at the end of March and at the time of the March reporting period, where 21 institutional holders increased their position in Celsion Corporation [NASDAQ:CLSN] by around 2,087,426 shares. Additionally, 14 investors decreased positions by around 988,355 shares, while 15 investors held positions by with 2,174,603 shares. The mentioned changes placed institutional holdings at 5,250,384 shares, according to the latest SEC report filing. CLSN stock had 7 new institutional investments in for a total of 391,784 shares, while 8 institutional investors sold positions of 229,703 shares during the same period.